Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data

Abstract This study investigates if laboratory data can be used to assess whether physician-retesting patterns are in line with established guidelines, and if these guidelines identify deteriorating patients in a timely manner. A total of 7594 patients with high cholesterol were studied, along with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jaspreet Pannu, Sarah Poole, Neil Shah, Nigam H. Shah
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/d3b8ac4ebf0f4204aa20a9fc704508bb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d3b8ac4ebf0f4204aa20a9fc704508bb
record_format	dspace
spelling	oai:doaj.org-article:d3b8ac4ebf0f4204aa20a9fc704508bb2021-12-02T11:52:15ZAssessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data10.1038/s41598-017-06492-62045-2322https://doaj.org/article/d3b8ac4ebf0f4204aa20a9fc704508bb2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-06492-6https://doaj.org/toc/2045-2322Abstract This study investigates if laboratory data can be used to assess whether physician-retesting patterns are in line with established guidelines, and if these guidelines identify deteriorating patients in a timely manner. A total of 7594 patients with high cholesterol were studied, along with 2764 patients with diabetes. More than 90% of borderline high cholesterol patients are retested within the 3 year recommended period, however less than 75% of pre-diabetic patients have repeated tests within the suggested 1-year time frame. Patients with borderline high cholesterol typically progress to full high cholesterol in 2–3 years, and pre-diabetic patients progress to full diabetes in 1–2 years. Data from routinely ordered laboratory tests can be used to monitor adherence to clinical guidelines. These data may also be useful in the design of adaptive testing strategies that reduce unnecessary testing, while ensuring that patient deterioration is identified in a timely manner. Established guidelines for testing of total serum cholesterol for hypercholesterolemia are appropriate and are well-adhered to, whereas guidelines for glycated hemoglobin A1c testing for type 2 diabetes mellitus could be improved to bring them in line with current practice and avoid unnecessary testing.Jaspreet PannuSarah PooleNeil ShahNigam H. ShahNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-5 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Jaspreet Pannu Sarah Poole Neil Shah Nigam H. Shah Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data
description	Abstract This study investigates if laboratory data can be used to assess whether physician-retesting patterns are in line with established guidelines, and if these guidelines identify deteriorating patients in a timely manner. A total of 7594 patients with high cholesterol were studied, along with 2764 patients with diabetes. More than 90% of borderline high cholesterol patients are retested within the 3 year recommended period, however less than 75% of pre-diabetic patients have repeated tests within the suggested 1-year time frame. Patients with borderline high cholesterol typically progress to full high cholesterol in 2–3 years, and pre-diabetic patients progress to full diabetes in 1–2 years. Data from routinely ordered laboratory tests can be used to monitor adherence to clinical guidelines. These data may also be useful in the design of adaptive testing strategies that reduce unnecessary testing, while ensuring that patient deterioration is identified in a timely manner. Established guidelines for testing of total serum cholesterol for hypercholesterolemia are appropriate and are well-adhered to, whereas guidelines for glycated hemoglobin A1c testing for type 2 diabetes mellitus could be improved to bring them in line with current practice and avoid unnecessary testing.
format	article
author	Jaspreet Pannu Sarah Poole Neil Shah Nigam H. Shah
author_facet	Jaspreet Pannu Sarah Poole Neil Shah Nigam H. Shah
author_sort	Jaspreet Pannu
title	Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data
title_short	Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data
title_full	Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data
title_fullStr	Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data
title_full_unstemmed	Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data
title_sort	assessing screening guidelines for cardiovascular disease risk factors using routinely collected data
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/d3b8ac4ebf0f4204aa20a9fc704508bb
work_keys_str_mv	AT jaspreetpannu assessingscreeningguidelinesforcardiovasculardiseaseriskfactorsusingroutinelycollecteddata AT sarahpoole assessingscreeningguidelinesforcardiovasculardiseaseriskfactorsusingroutinelycollecteddata AT neilshah assessingscreeningguidelinesforcardiovasculardiseaseriskfactorsusingroutinelycollecteddata AT nigamhshah assessingscreeningguidelinesforcardiovasculardiseaseriskfactorsusingroutinelycollecteddata
_version_	1718395133122052096

Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data

Ejemplares similares